共 50 条
- [41] No Superiority of Treatment With Osmotic Controlled-Release Oral Delivery System-Methylphenidate Over Short/Medium-Acting Methylphenidate Preparations in the Rate and Timing of Injuries in Children With Attention-Deficit/Hyperactivity Disorder CLINICAL NEUROPHARMACOLOGY, 2017, 40 (01) : 11 - 15
- [49] Randomised controlled trial of the short-term effects of osmotic-release oral system methylphenidate on symptoms and behavioural outcomes in young male prisoners with attention deficit hyperactivity disorder: CIAO-II study: commentary, Fazel BRITISH JOURNAL OF PSYCHIATRY, 2024, 225 (03) : 411 - 411